• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ADMA Biologics Inc - Common Stock (NQ:ADMA)

    8.610 +0.240 (+2.87%)
    Streaming Delayed Price Updated: 10:04 AM EDT, Jul 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 276,308
    Open 8.560
    Bid (Size) 8.600 (300)
    Ask (Size) 8.610 (800)
    Prev. Close 8.370
    Today's Range 8.520 - 8.670
    52wk Range 7.210 - 20.46
    Shares Outstanding 196,357,149
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    News headline image
    ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    From Kahn Swick & Foti, LLC
    Via GlobeNewswire

    Performance

    YTD
    -51.8%
    -51.8%
    1 Month
    +9.0%
    +9.0%
    3 Month
    -4.4%
    -4.4%
    6 Month
    -53.1%
    -53.1%
    1 Year
    -52.7%
    -52.7%

    More News

    Read More
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    Via Newsfile
    Topics Lawsuit
    News headline image
    ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.
    From Lowey Dannenberg, P.C.
    Via GlobeNewswire
    News headline image
    ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    Via Newsfile
    Topics Lawsuit
    News headline image
    ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA
    From Scott+Scott Attorneys at Law LLP
    Via Business Wire
    News headline image
    Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗
    Via The Motley Fool
    News headline image
    ADMA Biologics, Inc. (ADMA) Class Action Lawsuit Seeks Recovery for Investors; August 10, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    ADMA Biologics, Inc. (ADMA) Class Action Lawsuit Seeks Recovery for Investors; August 10, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    ADMA SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ADMA Biologics, Inc. Investors - Contact Kirby McInerney LLP by August 10, 2026
    From Kirby McInerney LLP
    Via GlobeNewswire
    News headline image
    ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    Via Newsfile
    Topics Lawsuit
    News headline image
    ADMA Biologics, Inc. (ADMA) Securities Fraud Class Action Lawsuit Filed; August 10, 2026, Lead Plaintiff Deadline
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    ADMA Biologics, Inc. (ADMA) Securities Fraud Class Action Lawsuit Filed; August 10, 2026, Lead Plaintiff Deadline
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
    From SkyMedia, LLC
    Via GlobeNewswire
    News headline image
    ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    Via Newsfile
    Topics Lawsuit

    Frequently Asked Questions

    Is ADMA Biologics Inc - Common Stock publicly traded?
    Yes, ADMA Biologics Inc - Common Stock is publicly traded.
    What exchange does ADMA Biologics Inc - Common Stock trade on?
    ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for ADMA Biologics Inc - Common Stock?
    The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market
    What is the current price of ADMA Biologics Inc - Common Stock?
    The current price of ADMA Biologics Inc - Common Stock is 8.610
    When was ADMA Biologics Inc - Common Stock last traded?
    The last trade of ADMA Biologics Inc - Common Stock was at 07/01/26 10:04 AM ET
    What is the market capitalization of ADMA Biologics Inc - Common Stock?
    The market capitalization of ADMA Biologics Inc - Common Stock is 1.69B
    How many shares of ADMA Biologics Inc - Common Stock are outstanding?
    ADMA Biologics Inc - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.